Systemic sulpiride modulates striatal blood flow: Relationships to spatial working memory and planning

NeuroImage

Volumn 20, Issue 4, 2003, Pages 1982-1994

  Mehta, Mitul A ^a   McGowan, Stephen W ^a   Lawrence, Andrew D ^b   Aitken, Michael R F ^c   Montgomery, Andrew J ^a   Grasby, Paul M ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b MRC COGNITION AND BRAIN SCIENCES UNIT   (United Kingdom)

^c UK   (United Kingdom)

Author keywords

Dopamine; PFC; Planning; Positron emission tomography; Sulpiride; Working memory

Indexed keywords

SULPIRIDE;

ADULT; ARTICLE; ATTENUATION; BRAIN BLOOD FLOW; COGNITION; CONTROLLED STUDY; DRUG EFFECT; DRUG HALF LIFE; HUMAN; HUMAN EXPERIMENT; MALE; NERVE CELL NETWORK; NEUROIMAGING; NORMAL HUMAN; PLANNING; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; STRIATE CORTEX; TASK PERFORMANCE; WORKING MEMORY;

EID: 0345734361     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2003.08.007     Document Type: Article

References (87)

1. Abi-Dargham A., Mawlawi O., Lombardo I., Gil R., Martinez D., Huang Y., Hwang D.R., Keilp J., Kochan L., Van Heertum R., Gorman J.M., Laruelle M. Prefrontal dopamine D1 receptors and working memory in schizophrenia. J. Neurosci. 22:2002;3708-3719.
2. Adriani W., Sargolini F., Coccurello R., Oliverio A., Mele A. Role of dopaminergic system in reactivity to spatial and non-spatial changes in mice. Psychopharmacology. 150:2000;67-76.
3. Aizman O., Brismar H., Uhlen P., Zettergren E., Levey A.I., Forssberg H., Greengard P., Aperia A. Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons. Nat. Neurosci. 3:2000;226-230.
4. Alexander G.E., Delong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking the basal ganglia and cortex. Ann. Rev. Neurosci. 9:1986;357-381.
5. Andersen S.L., Gazzara R.A. Effects of (-)-sulpiride on dopamine release in striatum of developing rats degree of depolarization influences responsiveness . J. Neurochem. 67:1996;1931-1937.
6. Arnsten A.F., Cai J.X., Steere J.C., Goldman-Rakic P.S. Dopamine D2 receptor mechanisms contribute to age-related cognitive decline the effects of quinpirole on memory and motor performance in monkeys . J. Neurosci. 15:1995;3429-3439.
7. Arnsten A.F. Catecholamine regulation of the prefrontal cortex. J. Psychopharmacol. 11:1997;151-162.
8. Arnsten A.F.T. Catecholamine modulation of prefrontal cortical cognitive function. Trends Cog. Sci. 2:1998;436-447.
9. Baddeley A. Working Memory. 1986;Clarendon Press, Oxford.
10. Baker S.C., Rogers R.D., Owen A.M., Frith C.D., Dolan R.J., Frackowiak R.S., Robbins T.W. Neural systems engaged by planning a PET study of the Tower of London task . Neuropsychologia. 34:1996;515-526.
11. Beiser D.G., Hua S.E., Houk J.C. Network models of the basal ganglia. Curr. Opin. Neurobiol. 7:1997;185-190.
12. Berretta S., Sachs Z., Graybiel A.M. Cortically driven Fos induction in the striatum is amplified by local dopamine D2-class receptor blockade. Eur. J. Neurosci. 11:1999;4309-4319.
13. Bigliani V., Mulligan R.S., Acton P.D., Visvikis D., Ell P.J., Stephenson C., Kerwin R.W., Pilowsky L.S. In vivo occupancy of striatal and temporal cortical D2/D3 dopamine receptors by typical antipsychotic drugs. [123I]epidepride single photon emission tomography (SPET) study. Br. J. Psychiat. 175:1999;231-238.
14. Brett M., Anton J.-L., Valabregue R., Poline J.-B. Region of interest analysis using an SPM toolbox. NeuroImage. 16:2002;497. [Abstract].
15. Brett M., Johnsrude I.S., Owen A.M. The problem of functional localization in the human brain. Nat. Rev. Neurosci. 3:2002;243-249.
16. Buchsbaum M.S., Potkin S.G., Siegel B.V. Jr., Lohr J., Katz M., Gottschalk L.A., Gulasekaram B., Marshall J.F., Lottenberg S., Teng C.Y., Abel L., Plon L., Bunney W.E. Jr. Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Arch. Gen. Psychiat. 49:1992;966-974.
17. Calabresi P., Pisani A., Centonze D., Bernardi G. Synaptic plasticity and physiological interactions between dopamine and glutamate in the striatum. Neurosci. Biobehav. Rev. 21:1997;519-523.
18. Caley C.F., Weber S.S. Sulpiride an antipsychotic with selective dopaminergic antagonist properties . Ann. Pharmacother. 29:1995;152-160.
19. Camps M., Cortes R., Gueye B., Probst A., Palacios J.M. Dopamine receptors in human brain autoradiographic distribution of D2 sites . Neuroscience. 28:1989;275-290.
20. Cochran W.G., Cox G.M. Experimental Designs. 1957;Wiley, New York.
21. Cohen J.D., Perlstein W.M., Braver T.S., Nystrom L.E., Noll D.C., Jonides J., Smith E.E. Temporal dynamics of brain activation during a working memory task. Nature. 386:1997;604-608.
22. Collins P., Wilkinson L.S., Everitt B.J., Robbins T.W., Roberts A.C. The effect of dopamine depletion from the caudate nucleus of the common marmoset (Callithrix jacchus) on tests of prefrontal cognitive function. Behav. Neurosci. 114:2000;3-17.
23. Cortes R., Camps M., Gueye B., Probst A., Palacios J.M. Dopamine receptors in human brain autoradiographic distribution of D1 and D2 sites in Parkinson syndrome of different etiology . Brain Res. 483:1989;30-38.
24. Dagher A., Owen A.M., Boecker H., Brooks D.J. Mapping the network for planning a correlational PET activation study with the Tower of London task . Brain. 122:1999;1973-1987.
25. Davatzikos C., Li H.H., Herskovits E., Resnick S.M. Accuracy and sensitivity of detection of activation foci in the brain via statistical parametric mapping a study using a PET simulator . Neuroimage. 13:2001;176-184.
26. Delgado A., Sierra A., Querejeta E., Valdiosera R.F., Aceves J. Inhibitory control of the GABAergic transmission in the rat neostriatum by D2 dopamine receptors. Neuroscience. 95:2000;1043-1048.
27. Diaz-Uriarte R. Incorrect analysis of crossover trials in animal behaviour research. Anim. Behav. 63:2002;815-822.
28. Elliott R., Sahakian B.J., Matthews K., Bannerjea A., Rimmer J., Robbins T.W. Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology. 131:1997;196-206.
29. Farde L., Wiesel F.A., Halldin C., Sedvall G. Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch. Gen. Psychiat. 45:1988;71-76.
30. Frank M.J., Loughry B., O'Reilly R.C. Interactions between frontal cortex and basal ganglia in working memory a computational model . Cogn. Affect. Behav. Neurosci. 1:2001;137-160.
31. Friston K.J., Buechel C., Fink G.R., Morris J., Rolls E., Dolan R.J. Psychophysiological and modulatory interactions in neuroimaging. NeuroImage. 6:1997;218-229.
32. Friston K.J., Holmes A.P., Worsley K.J., Poline J.-B., Frith C.D., Frackowiak R.S.J. Statistical Parametric Maps in functional imaging a general linear approach . Hum. Brain Mapp. 2:1995;189-210.
33. Goel V., Grafman J. Are the frontal lobes implicated in "planning" functions? Interpreting data from the Tower of Hanoi. Neuropsychologia. 33:1995;623-642.
34. Goldman-Rakic P.S. Circuitry of primate prefrontal cortex and regulation of behaviour by representational memory. Plum F. Handbook of Physiology Nervous System: Higher Functions of the Brain (part 1) . Vol. 5:1987;373-417 American Physiological Society, Bethesda, MD.
35. Grace A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity a hypothesis for the etiology of schizophrenia . Neuroscience. 41:1991;1-24.
36. Hammers A., Allom R., Koepp M.J., Free S.L., Myers R., Lemieux L., Mitchell T.N., Brooks D.J., Duncan J.S. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum. Brain Mapp. 19:2003;224-247.
37. Hall H., Sedvall G., Magnusson O., Kopp J., Halldin C., Farde L. Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology. 11:1994;245-256.
38. Hills M., Armitage P. The two-period cross-over clinical trial. Br. J. Clin. Pharmacol. 8:1979;7-20.
39. Hinton E.C., Montgomery A.J., Bantick R.A., Grasby P.M., Mehta M.A. Emotional memory and selective attention are impaired following 400mg sulpiride in healthy volunteers. J. Psychopharmacol. 16:(Suppl.):2002;A25.
40. Honey, G.D., Suckling, J., Zelaya, F., Long, C., Routledge, C., Jackson, S., Ng, V., Fletcher, P.C., Williams, S.C.R., Brown, J., Bullmore, E.T., 2003. Dopaminergic effects on physiological connectivity in a human cortico-striato-thalamic system. Brain 126, 1767-1781.
41. Jansma J.M., Ramsey N.F., Coppola R., Kahn R.S. Specific versus nonspecific brain activity in a parametric N-back task. Neuroimage. 12:2000;688-697.
42. Joel D., Weiner I. The connections of the dopaminergic system with the striatum in rats and primates an analysis with respect to the functional and compartmental organization of the striatum . Neuroscience. 96:2000;451-474.
43. 2 receptor explain the action of atypical antipsychotics? A new hypothesis . Am. J. Psychiat. 158:2001;360-369.
44. Kebabian J.W., Calne D.B. Multiple receptors for dopamine. Nature. 277:1979;93-99.
45. Kimberg D.Y., D'Esposito M., Farah M.J. Effects of bromocriptine on human subjects depends on working memory capacity. NeuroReport. 8:1997;3581-3585.
46. Kiyatkin E.A., Rebec G.V. Striatal neuronal activity and responsiveness to dopamine and glutamate after selective blockade of D1 and D2 dopamine receptors in freely moving rats. J. Neurosci. 19:1999;3594-3609.
47. Kocsis J.D., Sugimori M., Kitai S.T. Convergence of excitatory synaptic inputs to caudate spiny neurons. Brain Res. 124:1977;403-413.
48. Krimer L.S., Muly E.C., 3rd, Williams G.V., Goldman-Rakic P.S. Dopaminergic regulation of cerebral cortical microcirculation. Nat. Neurosci. 1:1998;286-289.
49. Lawrence A.D., Weeks R.A., Brooks D.J., Andrews T.C., Watkins L.H.A., Harding A.E., Robbins T.W., Sahakian B.J. The relationship between striatal dopamine receptor binding and cognitive performance in Huntington's disease. Brain. 121:1998;1343-1355.
50. Liddle P.F., Lane C.J., Ngan E.T. Immediate effects of risperidone on cortico-striato-thalamic loops and the hippocampus. Br. J. Psychiat. 177:2000;402-407.
51. Luciana M., Collins P.F. Dopaminergic modulation of working memory for spatial but not object cues in normal volunteers. J. Cogn. Neurosci. 9:1997;330-347.
52. Luciana M., Depue R.A., Arbisi P., Leon A. Facilitation of working memory in humans by a D2 dopamine receptor agonist. J. Cogn. Neurosci. 4:1992;58-67.
53. Mattay V.S., Callicott J.H., Bertolino A., Heaton I., Frank J.A., Coppola R., Berman K.F., Goldberg T.E., Weinberger D.R. Effects of dextroamphetamine on cognitive performance and cortical activation. Neuroimage. 12:2000;268-275.
54. McCulloch J., Kelly P.A.T., Ford I. Effect of apomorphine on the relationship between local cerebral glucose utilization and local berebral blood flow (with an appendix on its statistical analysis). J. Cereb. Blood Flow Metab. 2:1982;487-499.
55. McCulloch J. Mapping functional alterations in the CNS with 14C-deoxyglucose. Iversen L.L., Iversen S.D., Snyder S.H. Handbook of Psychopharmacology. Vol. 15:1982;321-409 Plenum Press, New York.
56. McDowell S., Whyte J., D'Esposito M. Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients. Brain. 121:1998;1155-1164.
57. Mehta M.A., Sahakian B.J., McKenna P.J., Robbins T.W. Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease. Psychopharmacology. 146:1999;162-174.
58. Mehta M.A., Owen A.M., Sahakian B.J., Mavaddat N., Pickard J.D., Robbins T.W. Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J. Neurosci. 20:2000;RC65. [Online].
59. Mehta M.A., Swainson R., Ogilvie A.D., Sahakian B.J., Robbins T.W. Improved short-term spatial memory but impaired reversal learning following the dopamine D2 agonist bromocriptine in human volunteers. Psychopharmacology. 159:2001;10-20.
60. Miller D.D., Andreasen N.C., O'Leary D.S., Rezai K., Watkins G.L., Ponto L.L., Hichwa R.D. Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography. Neuropsychopharmacology. 17:1997;230-240.
61. Müller U., von Cramon D.Y., Pollmann S. D1- versus D2-receptor modulation of visuospatial working memory in humans. J. Neurosci. 18:1998;2720-2728.
62. Myrtek M., Foerster F. The law of initial value a rare exception . Biol. Psychol. 22:1985;227-237.
63. Nelson H.E., Willison J.R. The Revised National Adult Reading Test - Test Manual. 1991;NFER-Nelson, Windsor, U.K.
64. Olsson H., Farde L. Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy - A simulation study based on experimental data. Neuroimage. 14:2001;936-945.
65. Owen A.M., Downes J.J., Sahakian B.J., Polkey C.E., Robbins T.W. Planning and spatial working memory following frontal lobe lesions in man. Neuropsychologia. 28:1990;1021-1034.
66. Owen A.M., Doyon J., Dagher A., Sadikot A., Evans A.C. Abnormal basal ganglia outflow in Parkinson's disease identified with PET implications for higher cortical functions . Brain. 121:1998;949-965.
67. Owen A.M., Doyon J., Petrides M., Evans A.C. Planning and spatial working memory a positron emission tomography study in humans . Eur. J. Neurosci. 8:1996;353-364.
68. Owen A.M., Iddon J.L., Hodges J.R., Summers B.A., Robbins T.W. Spatial and non-spatial working memory at different stages of Parkinson's disease. Neuropsychologia. 35:1997;519-532.
69. Owen A.M., Sahakian B.J., Hodges J.R., Polkey C.E., Summers B.A., Robbins T.W. Dopamine-dependent fronto-striatal planning deficits in early Parkinson's disease. Neuropsychology. 9:1995;126-140.
70. Parent A., Hazrati L.N. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. Brain Res. Rev. 20:1995;91-127.
71. Pizzolato G., Soncrant T.T., Larson D.M., Rapoport S.I. Stimulatory effect of the D2 antagonist sulpiride on glucose utilization in dopaminergic regions of rat brain. J. Neurochem. 49:1987;631-638.
72. Price C.J., Friston K.J. Cognitive conjunction a new approach to brain activation experiments . Neuroimage. 5:1996;261-270.
73. Raichle M.E., Martin W., Herscovitch P. Brain blood flow measured with H215O. II, Implementation and validation. J. Nucl. Med. 24:1983;790-798.
74. Rebec G.V., Christensen J.R., Guerra C., Bardo M.T. Regional and temporal differences in real-time dopamine efflux in the nucleus accumbens during free-choice novelty. Brain Res. 776:1997;61-67.
75. Rowe J.B., Owen A.M., Johnsrude I.S., Passingham R.E. Imaging the mental components of a planning task. Neuropsychologia. 39:2001;315-327.
76. Sawaguchi T. The role of D1-dopamine receptors in working memory-guided movements mediated by frontal cortical areas. Parkinsonism Rel. Dis. 7:2001;9-19.
77. Schultz W., Dayan P., Montague P.R. A neural substrate of prediction and reward. Science. 275:1997;1593-1599.
78. Selemon L.D., Goldman-Rakic P.S. Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey. J. Neurosci. 5:1985;776-794.
79. Shallice T. Specific impairments in planning. Philos. Trans. R. Soc. Lond. B Biol. Sci. 298:1982;199-209.
80. Spinks T.J., Jones T., Bloomfield P.M., Bailey D.L., Miller M., Hogg D., Jones W.F., Vaigneur K., Reed J., Young J., Newport D., Moyers C., Casey M.E., Nutt R. Physical characteristics of the ECAT EXACT3D positron tomograph. Phys. Med. Biol. 45:2000;2601-2618.
81. Toda N. Influence of dopamine and noradrenaline on isolated cerebral arteries of the dog. Br. J. Pharmacol. 58:1976;121-126.
82. Vincent S.L., Khan Y., Benes F.M. Cellular colocalization of dopamine D1 and D2 receptors in rat medial prefrontal cortex. Synapse. 19:1995;112-120.
83. von Bahr C., Wiesel F.-A., Movin G., Eneroth P., Jansson P., Nilsson L., Ogenstad S. Neuroendocrine responses to a single oral dose of remoxipride and sulpiride in healthy female and male volunteers. Psychopharmacology. 130:1991;443-448.
84. Wiesel F.A., Alfredsson G., Ehrnebo M., Sedvall G. Prolactin response following intravenous and oral sulpiride in healthy human subjects in relation to sulpiride concentrations. Psychopharmacology. 76:1982;44-47.
85. Wik G., Wiesel F.A., Sjogren I., Blomqvist G., Greitz T., Stone-Elander S. Effects of sulpiride and chlorpromazine on regional cerebral glucose metabolism in schizophrenic patients as determined by positron emission tomography. Psychopharmacology. 97:1989;309-318.
86. Worsley K.J., Marrett S., Neelin P., Vandal A.C., Friston K.J., Evans A.C. A unified statistical approach for determining significant signals in images of cerebral activation. Hum. Brain Mapp. 4:1996;58-73.
87. Zurowski B., Gostomzyk J., Gron G., Weller R., Schirrmeister H., Neumeier B., Spitzer M., Reske S.N., Walter H. Dissociating a common working memory network from different neural substrates of phonological and spatial stimulus processing. Neuroimage. 15:2002;45-57.